Eli Lilly and Co is a big company that makes medicine. Some people who have a lot of money think the price of this company's stock will go down, so they are selling some of their shares to make a profit. Other people think the price will stay the same or go up, so they are keeping their shares. The article is about what these rich and smart people are doing with their money in relation to Eli Lilly and Co. Read from source...

- The article title is misleading and sensationalist, implying that some large investors are secretly betting on Eli Lilly and Co against the market. However, the article does not provide any evidence or reason for why these whales would have such a negative outlook on the company.
- The article relies heavily on options history data from Benzinga Insights, which is not a reliable source of information. Options history data can be manipulated, inaccurate, or incomplete, and does not reflect the actual intentions or strategies of the investors who trade them.
- The article uses vague terms like "unusual trades" and "bullish/bearish tendencies" without explaining what they mean or how they are measured. This creates confusion and ambiguity for the readers, who may not understand the difference between options trading and stock ownership, or the implications of these statistics for Eli Lilly and Co's performance.
- The article does not provide any context or background information on Eli Lilly and Co, such as its history, products, market position, competitors, or challenges. This makes it difficult for the readers to evaluate the relevance and credibility of the options data and the whales' bets.

Based on the article titled `This Is What Whales Are Betting On Eli Lilly and Co`, I have analyzed the options history for Eli Lilly and Co and identified 18 unusual trades. These are trades that involve a large amount of money or a high volume compared to the typical trading activity for this stock. Out of these, 27% of traders were bullish, while 38% showed bearish tendencies. Ou